A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH)
A Randomized Controlled Clinical Trial of an Internet-based Prevention Intervention to Reduce STI in High-risk HIV Infected MSM
1 other identifier
interventional
181
1 country
3
Brief Summary
This is a CCTG sponsored trial in collaboration with UCSD-AVRC investigators to get more information about the methods that are used on the internet to provide information on how to reduce the risk of giving or getting infections that are often or usually passed from one person to another during sexual or intimate contact (sexually transmitted infection (STI)). STIs include chlamydia, gonorrhea and syphilis. The purpose of this study is to develop methods that will allow someone who is living with HIV an easy way that they can get information and learn of ways on their own that can decrease their chances of getting sexually transmitted infections and ways that they can reduce the chance that they may transmit HIV to others.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2010
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 9, 2010
CompletedFirst Submitted
Initial submission to the registry
September 8, 2010
CompletedFirst Posted
Study publicly available on registry
September 10, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 9, 2017
CompletedMay 12, 2020
May 1, 2020
7.3 years
September 8, 2010
May 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
STI incidence
* To compare the composite STI incidence of syphilis or Chlamydia trachomatis (CT) or Neisseria gonorrhea (GC) at any mucosal site among sexually active HIV-infected men during 12 months participation in an Internet risk reduction intervention compared to those that receive a survey instrument alone. * To compare the incidence of nonspecific urethritis by urinalysis and testing for Mycoplasma genitalum and trichomonas sp. among sexually active HIV-infected men during 12 months participation in an Internet risk reduction intervention compared to those that receive a survey instrument alone.
Baseline and follow-up visits every 3 months
Secondary Outcomes (1)
Evaluate risk factors of STIs
Baseline, follow-up visits every 3 months
Study Arms (2)
Internet-based counseling
EXPERIMENTALCompletes surveys monthly about their sexual and drug use behaviors as well as receives information designed to help reduce the chances of getting an STI.
Survey Alone
NO INTERVENTIONCompletes surveys monthly about their sexual and drug use behaviors
Interventions
Internet-based intervention that assesses transmission risk and provides prevention messages
Eligibility Criteria
You may qualify if:
- HIV-1 infection, as documented by any licensed screening antibody test, such as ELISA, and confirmed by a second antibody test, such as Western blot, or detectable plasma HIV-1 RNA at any time prior to study entry. If an ELISA or Western Blot are not available, HIV infection may be documented by two HIV RNA values \> 2000 copies/mL, drawn at least 24 hours apart. The HIV RNA assays should have been run at a CLIA approved laboratory or equivalent.
- years of age or older.
- Male.
- At least one of the following:
- An HIV negative or unknown status sexual partner in the past three months.
- A sexually transmitted disease in the past 1 year (other than HIV).
- More than 2 male partners in past year.
- Unprotected anal sex in past 3 month.
- Capable of signing written informed consent.
- Read and comprehend English
- Adequate computer skills for study.
You may not qualify if:
- Uncontrolled psychiatric condition.
- Drug or alcohol users with use that in the opinion of the investigator, would limit follow-up and adequate consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Diegolead
- University of California, Los Angelescollaborator
- University of Southern Californiacollaborator
- California HIV/AIDS Research Programcollaborator
Study Sites (3)
University of Southern California
Los Angeles, California, 90033, United States
University of California, San Diego
San Diego, California, 92103, United States
University of California, Los Angeles (Harbor)
Torrance, California, 90502, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sheldon Morris, MD, MPh
UC San Diego AntiViral Research Center (AVRC)
- STUDY CHAIR
Joel Milam, PhD
University of California, San Diego
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
September 8, 2010
First Posted
September 10, 2010
Study Start
July 9, 2010
Primary Completion
October 18, 2017
Study Completion
November 9, 2017
Last Updated
May 12, 2020
Record last verified: 2020-05